《復牌表現》華晨(01114.HK)履行所有復牌指引 復牌曾逆市挫71%
停牌逾一年半的華晨中國(01114.HK)履行所有復牌指引,該股今天(10月5日)復牌曾追挫71.2%,低見2.1元創至少逾2010年次季以來逾十二年低,隨後略為喘定,半日收2.83元,追挫61.2%,成交激增至1.86億股,涉資逾5億元。
華晨公布,公司已履行所有復牌指引,主要包括對未經授權擔保及額外事宜進行適當之獨立調查、公布調查發現及對業務營運及財務狀況之影響,並採取適當之整改措施;發表所有尚未發表之財務業績,以及處理任何審計修改;及進行獨立內部監控檢討,證明公司設有充分之內部監控及程序,以履行上市規則下之責任。公司將繼續與聯交所合作,協助調查違反上市規則之情況。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.